Mesoblast Ltd - ADR Stock, NASDAQ:MESO
55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000
Number of Employees: 77
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.